Back
Novartis AG 10K Form
Sell
50
NVS
Novartis AG
Last Price:
$136.08
Seasonality Move:
-1.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVS News And Ratings
See the #1 stock for the next 7 days that we like better than NVS
NVS Financial Statistics
Sales & Book Value
| Annual Sales: | $50.3B |
|---|---|
| Cash Flow: | $5.7B |
| Price / Cash Flow: | 15.64 |
| Annual Sales: | $23.10 |
| Price / Book: | 5.89 |
Profitability
| EPS (TTM): | 7.33300 |
|---|---|
| Net Income (TTM): | $14.4B |
| Gross Margin: | $37.5B |
| Return on Equity: | 33.87% |
| Return on Assets: | 13.81% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
-
The Gross Profit Margin over the past 32 years for NVS is 74.53%.
-
The Selling, General & Administrative Expenses for NVS have been equal to 24.97% of Gross Profit Margin.
-
The Research & Development expenses have been 18.90% of Revenue.
-
The Interest Expense is 8.69% of Operating Income.
-
The Net Earning history of NVS is 23.73% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 21 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVS |
| CUSIP: | 66987V |
| Website: | novartis.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 0.88 |
| Quick Ratio: | 0.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.2 |
|---|---|
| Forward P/E Ratio: | 14.76 |
NVS Technical Analysis vs Fundamental Analysis
Sell
50
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a SellThe current Novartis AG [NVS] share price is $136.06. The Score for NVS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.